投稿问答最小化  关闭

万维书刊APP下载
您的位置:万维书刊网 >> 期刊动态

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY《美国鼻科学与过敏杂志》投稿须知(官网信息)

2021/7/20 8:22:23 来源:官网信息 阅读:541 发布者:
编者按:以下信息,由万维书刊网根据期刊官网信息整理发布!仅供投稿参考!

Manuscript Submission Guidelines: American Journal of Rhinology & Allergy

This Journal is a member of the Committee on Publication Ethics

This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/ajra to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

Only manuscripts of sufficient quality that meet the aims and scope of American Journal of Rhinology & Allergy will be reviewed.

There are no fees payable to submit or publish in this journal.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that American Journal of Rhinology & Allergy may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy. If your paper is accepted, you must include a link on your preprint to the final version of your paper.

If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal

1. What do we publish?

1.1 Aims & Scope

Before submitting your manuscript to American Journal of Rhinology & Allergy, please ensure you have read the Aims & Scope.

1.2 Article types

American Journal of Rhinology & Allergy publishes peer-reviewed original laboratory and/or clinical research (2,500 words), reviews (3,000 words), letters to the editor (500 words and 5 references), solicited meeting papers (2,500 words), and solicited “How I Do It” papers (200 word abstract, 750 words, and 5 references). Note: Word counts do not include abstracts and references.

Additional information for solicited manuscripts:

Meeting papers: The corresponding scientific meeting should be included on the title page in the format of the name of the meeting, city, state (or country), date of meeting (i.e. “Presented at the North American Rhinology & Allergy Conference, St. Thomas, Virgin Islands, January 14, 2016”)

How I Do It” papers: Solicited submissions should report on novel and cutting edge techniques addressing clinical problems within the fields of allergy and rhinology. Submissions should enable the reader to both understand the problem and replicate the technique if they so choose. Preference will be given to submissions with high quality figures and videos.

Format for “How I Do It” solicited submissions:

Abstract: Up to 200 words

Sections: Introduction, Materials and Methods, Results, Discussion, Conclusion

Word Count: Approximately 750 words and up to 5 references

Figures: 1-3 still high quality photos, ~1 MB, accepted formats include .tif, .jpeg, .eps

Tables: up to 2 tables

Video 3-5MB, Narration preferred, formats accepted Quick Time Movie (.mov) or Windows Media Video (.wmv)

American Journal of Rhinology & Allergy generally does not accept case reports for publication. Case reports that are truly unique and have an exceptional teaching value will be referred to the open access journal, Allergy & Rhinology, for consideration

1.3 Writing your paper

The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

1.3.1 Make your article discoverable

When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online

2. Editorial Policies

2.2 Authorship

Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

The list of authors should include all those who can legitimately claim authorship. This is all those who:

(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,

(ii) Drafted the article or revised it critically for important intellectual content,

(iii) Approved the version to be published,

(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

2.3 Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

2.3.1 Third party submissions

Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:

    Disclose this type of editorial assistance – including the individual’s name, company and level of input

    Identify any entities that paid for this assistance

    Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.

Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.

2.3.2 Writing assistance

Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.

2.4 Funding

American Journal of Rhinology & Allergy requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

2.5 Declaration of conflicting interests

It is the policy of American Journal of Rhinology & Allergy to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles. Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here

2.6 Research ethics and patient consent

Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants

All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

2.7 Clinical trials

American Journal of Rhinology & Allergy conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

2.8 Reporting guidelines

The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives

2.9 Research Data

The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the SAGE Research Data policy pages.

Subject to appropriate ethical and legal considerations, authors are encouraged to:

share your research data in a relevant public data repository

include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.

cite this data in your research

3. Publishing Policies

3.1 Publication ethics

SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway

3.1.1 Plagiarism

American Journal of Rhinology & Allergy and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

3.1.2 Prior publication

If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

3.2 Contributor’s publishing agreement

Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway

3.3 Open access and author archiving

American Journal of Rhinology & Allergy offers optional open access publishing via the SAGE Choice programme. For more information on Open Access publishing options at SAGE please visit SAGE Open Access. For information on funding body compliance, and depositing your article in repositories, please visit SAGE’s Author Archiving and Re-Use Guidelines and Publishing Policies.

4. Preparing your manuscript for submission

4.1 Formatting

The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

1. Cover letter:

Declare intentions to publish in AJRA and confirm you have not submitted elsewhere

2. Title page:

Include full a non-declarant, relevant, and concise title in sentence format (only capitalize proper nouns). Do not include abbreviations or use trade names in the title.

First name, middle initial, last name of each author with highest academic degrees included (do not include fellowships). All contributing authors should be listed including any professional writing assistance.

Name of Departments and Institutions to which work should be attributed

Disclaimers if any should be limited to those pertaining to this work.

If this work is supported through NIH funding, this must be noted in the footnote.

Keywords (10 key words are mandatory) Selecting appropriate keywords is essential to your research being discovered by others. Keywords should be mentioned in the abstract.

Include date of presentation at scientific meeting (if any).

Include corresponding author’s telephone number and e-mail address.

3. Abstract: All manuscript types with the exception of the Letters to the Editors should include a structured abstract, no longer than 300 words, to precede article. Only include acronyms or abbreviations if the phrase appears more than three times in the abstract. The abstract should NOT contain brand names, trademarks or references. Clinical trial registration numbers should be listed last in the abstract. Structure abstract into the following sections:

Background – Describe the problem that prompted the study

Objective – Describe the purpose of the study

Methods – Describe how the study was conducted

Results – Describe the most important findings

Conclusion – Describe the most important conclusion drawn from the study

Text: Manuscript should be typed double-spaced in a standard font such as Times New Roman, Arial, Courier, or Helvetica, in size 12. Text should be written in clear and concise English with proper use of grammar and syntax. Please add line numbers to your text so that reviewers can most accurately direct their feedback.

4. Acknowledgment: General acknowledgments for consultations, statistical analysis and such should be listed at the end of the text before the References. Include full names of individuals.

5. References (described below)

6. Tables, Figures, Illustrations (described below)

4.2 Artwork, figures and other graphics

For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines

……

更多详情:

https://journals.sagepub.com/author-instructions/AJR


本文评论

暂无相应记录!

首页<<1>>尾页共0页共0条记录
  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com